3Kantarjian HM, Talpaz M, Giles F, et al. New insights into the pathophysiotogy of chronic myeloid leukemia and imatinih resistance [ J ]. Ann Intern Med ,2006,145 ( 12 ) :913 - 923.
4Kantarjian H, Sawyers C, Hochhaus A, et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia[J]. N Engl J Med,2002,346(9) :645 -652.
5Cortes JE, Talpaz M, Kantarjian H. Chronic myelogenous leukemia: a review [ J ]. Am J Med, 1996,100 ( 5 ) :555 - 570.
6Cuenco GM, Ren R. Cooperation of BCR - ABL and AMLI/MDSI/EVII in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia [ J ]. Oncogene,2001,20 ( 57 ) : 8236 - 8248.
7Dash AB, Williams IR, Kutok JL, et al. A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9 [ J ].Proc Natl Acad Sci USA,2002,99 ( 11 ) :7622 - 7627.
8Feinstein E, Cimino G, Gale RP, et al. p53 in chronic myelogenous leukemia in acute phase [ J ]. Proc Natl Acad Sci USA, 1991,88 (14) : 6293 - 6297.
9Sill H, Goldman JM, Cross NC. Homozygous deletions of the p16 tumor - suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia[ J ]. Blood, 1995,85 (8) :2013 - 2016.
4GHALAUT V S,PAHWA M B,SUNITA,et al.Alteration in lipid profile in patients of chronic myeloid leukemia before and after chemotherapy[J].Clin Chim Acta,2006,366(1/2):239-242.
5MAJA G,MIRJAM C C,DAIANA S,et al.Prognostic impact of plasma lipids in patients with lower respiratory tract infections -an observational study[J].Swiss Med Weekly,2009,139(11/12):166-172.
6L(O)PEZ BERMEJO A,CHICO JULI B,CASTRO A,et al.Alpha defensins 1,2,and 3:potential roles in dyslipidemia and vascular dysfunction in humans[J].Arterioscler Thromb Vasc Biol,2007,27(5):1166-1171.
7Tefferi A,Vardiman Jw.Classification and diagnosis of myeloproliferative neoplasms:the 2008 World HealthOrganization criteria and point-of-care diagnostic algorithms[J].Leukemia,2008,22(1):14-22.
8James C,Ugo V,LE COUEDIC,et al.A unique clonal JAK2mutation leading to constitutive signaling causes polycythemiavera[J].Nature,2005,434(7037):1144-1148.
9Dalal I,Arpaia E,Dadi H,et al.Cloning and characterization ofthe human homolog of mouse Jak2[J].Blood,1998,91(3):844-851.
